SOLARA ACTIVE PHARMA SCIENCES
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹1,444 Cr | ₹1,268 Cr | ₹1,617 Cr | ₹1,322 Cr | ₹1,387 Cr |
Sales | ₹1,374 Cr | ₹1,207 Cr | ₹1,564 Cr | ₹1,251 Cr | ₹1,292 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹6.21 Cr | ₹25 Cr | ₹14 Cr | ₹17 Cr | ₹30 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹64 Cr | ₹36 Cr | ₹39 Cr | ₹54 Cr | ₹65 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹1,444 Cr | ₹1,268 Cr | ₹1,617 Cr | ₹1,322 Cr | ₹1,387 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹7.05 Cr | ₹-259 Cr | ₹-2.15 Cr | ₹-54 Cr | ₹-34 Cr |
Raw Material Consumed | ₹782 Cr | ₹913 Cr | ₹727 Cr | ₹653 Cr | ₹739 Cr |
Opening Raw Materials | ₹131 Cr | ₹110 Cr | ₹98 Cr | ₹87 Cr | ₹85 Cr |
Purchases Raw Materials | ₹762 Cr | ₹880 Cr | ₹696 Cr | ₹634 Cr | ₹731 Cr |
Closing Raw Materials | ₹119 Cr | ₹131 Cr | ₹110 Cr | ₹98 Cr | ₹87 Cr |
Other Direct Purchases / Brought in cost | ₹7.88 Cr | ₹54 Cr | ₹43 Cr | ₹30 Cr | ₹9.08 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹108 Cr | ₹94 Cr | ₹85 Cr | ₹78 Cr | ₹79 Cr |
Electricity & Power | ₹106 Cr | ₹92 Cr | ₹84 Cr | ₹76 Cr | ₹78 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | ₹2.07 Cr | ₹1.58 Cr | ₹1.36 Cr | ₹1.46 Cr | ₹1.79 Cr |
Employee Cost | ₹229 Cr | ₹236 Cr | ₹229 Cr | ₹204 Cr | ₹186 Cr |
Salaries, Wages & Bonus | ₹189 Cr | ₹197 Cr | ₹188 Cr | ₹167 Cr | ₹155 Cr |
Contributions to EPF & Pension Funds | ₹19 Cr | ₹19 Cr | ₹18 Cr | ₹15 Cr | ₹14 Cr |
Workmen and Staff Welfare Expenses | ₹21 Cr | ₹22 Cr | ₹19 Cr | ₹16 Cr | ₹14 Cr |
Other Employees Cost | ₹0.05 Cr | ₹-1.31 Cr | ₹5.14 Cr | ₹5.60 Cr | ₹2.39 Cr |
Other Manufacturing Expenses | ₹92 Cr | ₹101 Cr | ₹96 Cr | ₹95 Cr | ₹102 Cr |
Sub-contracted / Out sourced services | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹17 Cr | ₹16 Cr |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹50 Cr | ₹54 Cr | ₹46 Cr | ₹48 Cr | ₹50 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹25 Cr | ₹30 Cr | ₹34 Cr | ₹30 Cr | ₹36 Cr |
General and Administration Expenses | ₹39 Cr | ₹49 Cr | ₹48 Cr | ₹48 Cr | ₹36 Cr |
Rent , Rates & Taxes | ₹3.60 Cr | ₹4.42 Cr | ₹4.51 Cr | ₹6.51 Cr | ₹6.60 Cr |
Insurance | ₹8.45 Cr | ₹13 Cr | ₹8.59 Cr | ₹7.70 Cr | ₹4.39 Cr |
Printing and stationery | ₹2.26 Cr | ₹2.22 Cr | ₹2.19 Cr | ₹2.76 Cr | ₹2.44 Cr |
Professional and legal fees | ₹17 Cr | ₹24 Cr | ₹27 Cr | ₹21 Cr | ₹12 Cr |
Traveling and conveyance | ₹5.74 Cr | ₹2.91 Cr | ₹2.27 Cr | ₹6.92 Cr | ₹6.47 Cr |
Other Administration | ₹2.44 Cr | ₹2.75 Cr | ₹3.26 Cr | ₹2.88 Cr | ₹3.21 Cr |
Selling and Distribution Expenses | ₹32 Cr | ₹30 Cr | ₹32 Cr | ₹25 Cr | ₹31 Cr |
Advertisement & Sales Promotion | ₹0.86 Cr | ₹0.38 Cr | ₹0.31 Cr | ₹1.56 Cr | ₹2.28 Cr |
Sales Commissions & Incentives | ₹5.12 Cr | ₹5.01 Cr | ₹5.31 Cr | ₹3.95 Cr | ₹4.03 Cr |
Freight and Forwarding | ₹26 Cr | ₹25 Cr | ₹26 Cr | ₹19 Cr | ₹25 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹22 Cr | ₹24 Cr | ₹16 Cr | ₹14 Cr | ₹27 Cr |
Bad debts /advances written off | ₹5.66 Cr | ₹8.82 Cr | - | ₹0.70 Cr | ₹0.52 Cr |
Provision for doubtful debts | - | - | ₹0.03 Cr | ₹0.27 Cr | ₹0.36 Cr |
Losson disposal of fixed assets(net) | ₹0.45 Cr | ₹0.77 Cr | - | ₹0.32 Cr | - |
Losson foreign exchange fluctuations | - | - | ₹1.69 Cr | ₹1.74 Cr | ₹9.81 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹11 Cr | ₹17 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹1,310 Cr | ₹1,188 Cr | ₹1,231 Cr | ₹1,062 Cr | ₹1,166 Cr |
Operating Profit (Excl OI) | ₹134 Cr | ₹80 Cr | ₹386 Cr | ₹259 Cr | ₹221 Cr |
Other Income | ₹23 Cr | ₹20 Cr | ₹29 Cr | ₹28 Cr | ₹12 Cr |
Interest Received | ₹5.78 Cr | ₹7.76 Cr | ₹14 Cr | ₹7.62 Cr | ₹1.61 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | ₹2.00 Cr | - | ₹0.44 Cr |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | ₹10 Cr | ₹1.75 Cr | ₹3.82 Cr | ₹1.83 Cr | ₹2.87 Cr |
Foreign Exchange Gains | ₹0.27 Cr | ₹2.42 Cr | ₹0.27 Cr | - | - |
Others | ₹6.48 Cr | ₹8.09 Cr | ₹8.46 Cr | ₹18 Cr | ₹7.46 Cr |
Operating Profit | ₹156 Cr | ₹100 Cr | ₹415 Cr | ₹287 Cr | ₹233 Cr |
Interest | ₹90 Cr | ₹75 Cr | ₹84 Cr | ₹78 Cr | ₹82 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹92 Cr | ₹72 Cr | ₹78 Cr | ₹73 Cr | ₹73 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹3.26 Cr | ₹2.86 Cr | ₹4.14 Cr | ₹2.66 Cr | ₹2.59 Cr |
Other Interest | ₹-5.65 Cr | ₹0.41 Cr | ₹2.45 Cr | ₹2.36 Cr | ₹6.64 Cr |
PBDT | ₹66 Cr | ₹25 Cr | ₹330 Cr | ₹209 Cr | ₹151 Cr |
Depreciation | ₹111 Cr | ₹112 Cr | ₹109 Cr | ₹94 Cr | ₹83 Cr |
Profit Before Taxation & Exceptional Items | ₹-45 Cr | ₹-88 Cr | ₹222 Cr | ₹115 Cr | ₹68 Cr |
Exceptional Income / Expenses | - | ₹-3.49 Cr | - | - | - |
Profit Before Tax | ₹-45 Cr | ₹-91 Cr | ₹222 Cr | ₹115 Cr | ₹68 Cr |
Provision for Tax | ₹-23 Cr | ₹-33 Cr | ₹0.15 Cr | ₹0.39 Cr | ₹0.58 Cr |
Current Income Tax | ₹-0.09 Cr | ₹0.17 Cr | ₹39 Cr | ₹21 Cr | ₹16 Cr |
Deferred Tax | ₹-22 Cr | ₹-33 Cr | ₹-39 Cr | ₹-21 Cr | ₹-14 Cr |
Other taxes | ₹-0.02 Cr | ₹0.06 Cr | - | ₹-0.14 Cr | ₹-1.43 Cr |
Profit After Tax | ₹-22 Cr | ₹-58 Cr | ₹221 Cr | ₹115 Cr | ₹67 Cr |
Extra items | - | - | - | - | ₹-7.68 Cr |
Minority Interest | ₹0.07 Cr | ₹0.14 Cr | ₹0.05 Cr | ₹0.09 Cr | ₹0.10 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹-22 Cr | ₹-58 Cr | ₹221 Cr | ₹115 Cr | ₹60 Cr |
Adjustments to PAT | ₹-0.47 Cr | - | - | - | - |
Profit Balance B/F | ₹274 Cr | ₹339 Cr | ₹140 Cr | ₹45 Cr | ₹-4.24 Cr |
Appropriations | ₹251 Cr | ₹281 Cr | ₹361 Cr | ₹159 Cr | ₹55 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹1.76 Cr | ₹6.98 Cr | ₹22 Cr | ₹19 Cr | ₹11 Cr |
Equity Dividend % | - | - | ₹70.00 | ₹20.00 | ₹50.00 |
Earnings Per Share | ₹-6.16 | ₹-16.15 | ₹61.62 | ₹42.69 | ₹23.09 |
Adjusted EPS | ₹-5.68 | ₹-14.89 | ₹56.79 | ₹39.34 | ₹21.28 |
Compare Income Statement of peers of SOLARA ACTIVE PHARMA SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SOLARA ACTIVE PHARMA SCIENCES | ₹3,290.8 Cr | -5.1% | -16.3% | 122.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SOLARA ACTIVE PHARMA SCIENCES | -5.1% |
-16.3% |
122.4% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses